ABVX: Abivax SA
Performance
ABVX -17.36%
Watchlist
Select an item
Summary
ABVX at a glance
ABVX returned -17.36% over the past year. Its worst drop in that year was -50.11%, smaller than 23% of stocks on Redstone, and its Sharpe ratio of 0.19 beats 35% of stocks on Redstone. It pays no dividends.
Current Drawdown
-40.13%
Rolling Volatility
48.30%
Actions
Metrics
Risk Indicators
Alpha4.91%
Beta1.17x
Sharpe0.19
Sortino0.29
Omega1.04
Calmar-0.35
Martin0.74
Profile
About ABVX
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.
- Sector
- Health Care
- Market cap
- $7.6B
- Listed
- Oct 2023
- Employees
- 69
- Website
- abivax.com
Comparisons